FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Advanced or Metastatic Breast Cancer
暂无分享，去创建一个
K. Goldberg | R. Pazdur | P. Zhao | Todd R. Palmby | G. Blumenthal | R. Sridhara | A. Ibrahim | J. Beaver | Paresma R. Patel | E. Bloomquist | Qi Liu | A. Tilley | Jingyu Yu | Y. Bi | W. Pierce | Elleni Alebachew | Shenghui Tang | W. Fu | Anand B Shah | C. J. Chang | Paresma Patel | C. Chang | Kirsten B. Goldberg | Amy Tilley | C.J. George Chang